Birth and parental characteristics and risk of neuroblastoma in a population-based Norwegian cohort study

British Journal of Cancer

Volumn 99, Issue 7, 2008, Pages 1165-1169

  Bjorge T ^a,b   Engeland, A ^a,b   Tretli, S ^c   Heuch, I ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

Cohort study; Neuroblastoma; Norway; Perinatal factors

Indexed keywords

ADRENAL MEDULLA TUMOR; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; PREECLAMPSIA; PRIORITY JOURNAL; RISK FACTOR;

CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DELIVERY, OBSTETRIC; HUMANS; INFANT; NEUROBLASTOMA; NORWAY; PARENTS; RISK FACTORS;

EID: 53049102604     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604646     Document Type: Article

References (18)

1. Bjørge T, Cnattingius S, Lie RT, Tretli S, Engeland A (2008) Cancer risk in children with birth defects and in their families: a population based cohort study of 5.2 million children from Norway and Sweden. Cancer Epidemiol Biomarkers Prev 17: 500-506
2. Buck GM, Michalek AM, Chen CJ, Nasca PC, Baptiste MS (2001) Perinatal factors and risk of neuroblastoma. Paediatr Perinat Epidemiol 15: 47-53
3. Cancer Registry of Norway (2007) Cancer in Norway 2006
4. Cox DR, Oakes D (1984) Analysis of Survival Data. Chapman and Hall Ltd: London
5. Goodman MT, Gurney JG, Smith MA, Olshan AF (1999) Sympathetic nervous system tumors. In Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds) pp 65-72. NIH: Bethesda
6. Hamrick SE, Olshan AF, Neglia JP, Pollock BH (2001) Association of pregnancy history and birth characteristics with neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. Paediatr Perinat Epidemiol 15: 328-337
7. Huddart SN, Mann JR (1991) Screening for neuroblastoma. Arch Dis Child 66: 1272-1274
8. Irgens LM (2000) The Medical Birth Registry of Norway. Epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand 79: 435-439
9. Johnson KJ, Puumala SE, Soler JT, Spector LG (2008) Perinatal characteristics and risk of neuroblastoma. Int J Cancer 123: 1166-1172
10. Kaatsch P, Steliarova-Foucher E, Crocetti E, Magnani C, Spix C, Zambon P (2006) Time trends of cancer incidence in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 42: 1961-1971
11. Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369: 2106-2120
12. Menegaux F, Olshan AF, Reitnauer PJ, Blatt J, Cohn SL (2005) Positive association between congenital anomalies and risk of neuroblastoma. Pediatr Blood Cancer 45: 649-655
13. Narod SA, Hawkins MM, Robertson CM, Stiller CA (1997) Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet 60: 474-485
14. Schuz J, Kaletsch U, Meinert R, Kaatsch P, Spix C, Michaelis J (2001) Risk factors for neuroblastoma at different stages of disease. Results from a population-based case-control study in Germany. J Clin Epidemiol 54: 702-709
15. Spix C, Pastore G, Sankila R, Stiller CA, Steliarova-Foucher E (2006) Neuroblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 42: 2081-2091
16. SPSS Inc. (2006) SPSS for Windows Release 15.0.1. 22-11-2006
17. The Cancer Registry of Norway (2008) The Cancer Registry of Norway, http://www.kreftregisteret.no/
18. Urayama KY, Von Behren J, Reynolds P (2007) Birth characteristics and risk of neuroblastoma in young children. Am J Epidemiol 165: 486-495